跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,436 条关于
“ABL Myristoyl Pocket”
全部
8,436
临床试验
6,434
药物
607
机构
310
资讯
1,085
去年
FDA Approves Scemblix (asciminib) for First-Line Treatment of Chronic Myelogenous Leukemia
5年前
FDA Approves Scemblix (asciminib) for Chronic Myeloid Leukemia with Novel Mechanism
4年前
Scemblix Receives Positive CHMP Opinion for CML Treatment After TKI Failure
4年前
Scemblix Receives European Commission Approval for CML Treatment After TKI Failure
4年前
Scemblix Receives Positive CHMP Opinion for CML Treatment After TKI Failure
去年
FDA Approves Asciminib (Scemblix) for Newly Diagnosed Chronic Myeloid Leukemia
去年
FDA Approves Scemblix (asciminib) for Newly Diagnosed Chronic Myeloid Leukemia
去年
FDA Approves Novartis' Scemblix for Newly Diagnosed Chronic Myeloid Leukemia
去年
Novartis' Scemblix Shows Promising 96-Week Data in First-Line CML Treatment
3年前
Asciminib Demonstrates Durable Efficacy and Safety in Heavily Pretreated CML-CP Patients
第 1 页,共 109 页
上一页
下一页